ETBX-021 Ad5 [E1-, E2b-]-HER2/Neu vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ETBX-021 Ad5 [E1-, E2b-]-HER2/Neu vaccine, covering 2025-01-13 to 2025-01-13. Get the full timeline:
Most recent: Clinical Trial Update: QUILT-3.013: Study of Ad5 [E1-, E2b-]-HER2/Neu Vaccine (ETBX-021) in Subjects With Unresectable Locally Advanced or Metastatic HER2-Expressing Breast Cancer [Phase 1]